| Website | marvalbiosciences... |
| Category | BioTech |
| Employees |
| TOTAL | $2.5M |
| FUNDING TOTAL | $2.5M |
| Series B, 1/10 DFJ Frontier Mercury Fund | $2.5M |
Marval Biosciences, Inc., a life sciences company, develops biomedical imaging agents. It develops liposomal nanocarriers to deliver CT contrast agents that are used to diagnose acute chest pain and reduce toxicity to patients.
